KinexaTherapeutics ApS: Financial statements 2025
CVR: 43952633
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
KinexaTherapeutics ApS (CVR 43952633) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -129,726 and a net result of DKK -56,425 compared with DKK -286,245 the year before. Equity in the 2025 report amounted to DKK -315,170.
- Gross Profit
- DKK -129,726
- Profit/Loss
- DKK -56,425
- Equity
- DKK -315,170
- Total Assets
- DKK 146,166
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -130K | -56K | -315K | 0 |
| 2024 | - | -276K | -286K | -259K | - |
Official annual report
How creditworthy is KinexaTherapeutics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
KinexaTherapeutics ApS has published its annual report for 2024. Gross profit came to DKK -276,347, and the net result was DKK -286,245.
About KinexaTherapeutics ApS
KinexaTherapeutics ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Rune Risgaard, Lars Jørgensen and Mikkel Bender. The company is owned by MEVA HOLDING ApS, CORIS Holding ApS and LAJOVI Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -129,726 and a net result of DKK -56,425 compared with DKK -286,245 the year before. Equity in the 2025 report amounted to DKK -315,170.